{"product_id":"pharma-supply-chain-delivering-patient-value-for-pharmaceuticals-and-biologics-9780470555170","title":"Pharma Supply Chain Delivering Patient Value for Pharmaceuticals and Biologics","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"A recommended read for all wishing to shift performance to greater levels.\" (Supply Management, 1 February 2012)\u003cbr\u003e \u003cbr\u003e   \u003cp\u003e\"This book is ideal reading for those entering or currently working in the field of supply chain management, such as clinical supply managers, or those in operations or production and planning ... This book would be an excellent resource for small pharmaceutical companies that may have limited experience of supply chain implementation or outsourcing, giving a thorough overview of the process and plenty of food for thought.\" (The Pharmaceutical Journal, 16 November 2011)\u003c\/p\u003e \u003cp\u003e\"This is a solid text that is equally suitable for the newcomer or experienced profesional in the pharmaceutical\/biologics industries . . . Overall, I recommend the book for its educational perspective on the industry and the significance of effective SCM for its future success.\" (\u003ci\u003eQuality World\u003c\/i\u003e, 1 July 2011)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eCONTRIBUTORS xiii\u003c\/p\u003e \u003cp\u003ePREFACE xxi\u003c\/p\u003e \u003cp\u003e\u003cb\u003eI SURVEYING AND MAPPING THE TERRITORY 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Setting a Transformational Agenda 3\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1.1 Aims and Aspirations of the Book 3\u003c\/p\u003e \u003cp\u003e1.2 Book Format 5\u003c\/p\u003e \u003cp\u003e1.3 Intended Readership 6\u003c\/p\u003e \u003cp\u003e1.4 A Book About Two Worlds in Contrast 8\u003c\/p\u003e \u003cp\u003e1.5 The Pharmaceutical Lottery 8\u003c\/p\u003e \u003cp\u003e1.6 Supply Chain Management in Context 17\u003c\/p\u003e \u003cp\u003e1.7 The History of Supply and Value Generation 22\u003c\/p\u003e \u003cp\u003e1.8 The Development of Processes to Manage the Supply Chain 24\u003c\/p\u003e \u003cp\u003e1.9 Life in SCM 25\u003c\/p\u003e \u003cp\u003e1.10 Moving Forward 26\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Plotting a Course to Patient Value 29\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2.1 Why Focus on Patient Value? 29\u003c\/p\u003e \u003cp\u003e2.2 Where Does the Patient Currently Fit? 29\u003c\/p\u003e \u003cp\u003e2.3 Why Is It Necessary to Plot a Course? 33\u003c\/p\u003e \u003cp\u003e2.4 Understanding How the Course Is Presently Set 39\u003c\/p\u003e \u003cp\u003e2.5 Capturing Value for Patients 42\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Pharmaceutical Drug Development 45\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e3.1 Drug Development’s Role in the Supply Chain 45\u003c\/p\u003e \u003cp\u003e3.2 Introduction to Drug Development 47\u003c\/p\u003e \u003cp\u003e3.3 The Medicinal Product 48\u003c\/p\u003e \u003cp\u003e3.4 Clinical Trials 49\u003c\/p\u003e \u003cp\u003e3.5 Related Development Programs 52\u003c\/p\u003e \u003cp\u003e3.6 Managing Clinical Programs 57\u003c\/p\u003e \u003cp\u003e3.7 Regulatory Affairs and Authorities 58\u003c\/p\u003e \u003cp\u003e3.8 Supply Chain Management in Development Programs 65\u003c\/p\u003e \u003cp\u003e3.9 Manufacture and Supply of Commercial Products 68\u003c\/p\u003e \u003cp\u003e3.10 Supply Chain Management for Commercial Products 69\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 End-to-End Pharmaceutical Supply Chains 73\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 73\u003c\/p\u003e \u003cp\u003e4.2 Where Does Responsibility for the Supply Chain Lay? 74\u003c\/p\u003e \u003cp\u003e4.3 Sponsoring Companies, License Holders, and Their Supply Chains 75\u003c\/p\u003e \u003cp\u003e4.4 Supply Chains for Small-Molecule Products 76\u003c\/p\u003e \u003cp\u003e4.5 Starting at the Final Destination 78\u003c\/p\u003e \u003cp\u003e4.6 How Drugs Enter the Body 78\u003c\/p\u003e \u003cp\u003e4.7 Design of Drug Delivery Systems 79\u003c\/p\u003e \u003cp\u003e4.8 What This Means for the Supply Chain 82\u003c\/p\u003e \u003cp\u003e4.9 Key Aspects of GMP and GDP in Relation to SCM 82\u003c\/p\u003e \u003cp\u003e4.10 Overview of the Stages on Route to Patient Delivery 86\u003c\/p\u003e \u003cp\u003e4.11 Manufacture and Supply of Biological Entities 90\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Why Pharma Supply Chains Don’t Perform 103\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5.1 Supply Chain Underperformance 103\u003c\/p\u003e \u003cp\u003e5.2 Is There a Case to Answer? 103\u003c\/p\u003e \u003cp\u003e5.3 Birth to Infancy: The Supply Chain Critical Stage 104\u003c\/p\u003e \u003cp\u003e5.4 Commercial Supply Under the Patent Protection Umbrella 111\u003c\/p\u003e \u003cp\u003e5.5 What This Means for the Pharmaceutical Supply Chain 116\u003c\/p\u003e \u003cp\u003e\u003cb\u003eII BUILDING A KNOWLEDGE FOUNDATION IN SCM 125\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Supply Chain Management as a Competitive Weapon 127\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6.1 Competition and Business Strategy 127\u003c\/p\u003e \u003cp\u003e6.2 The Marketing Mix 128\u003c\/p\u003e \u003cp\u003e6.3 Porter’s Five Forces 128\u003c\/p\u003e \u003cp\u003e6.4 Porter’s Generic Competitive Strategies 129\u003c\/p\u003e \u003cp\u003e6.5 Porter’s Value Chain 129\u003c\/p\u003e \u003cp\u003e6.6 Competitive Strategy and Customers 133\u003c\/p\u003e \u003cp\u003e6.7 The Japanese Experience 142\u003c\/p\u003e \u003cp\u003e6.8 Total Quality Management 142\u003c\/p\u003e \u003cp\u003e6.9 Lean Thinking 143\u003c\/p\u003e \u003cp\u003e6.10 Focusing on Value for Money 146\u003c\/p\u003e \u003cp\u003e6.11 SCM Processes in Competitive Strategy 148\u003c\/p\u003e \u003cp\u003e6.12 SCM in Biotech and Virtual Companies 150\u003c\/p\u003e \u003cp\u003e6.13 Competition in Pharmaceuticals 152\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Supply Chain Management Holistic 155\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7.1 The Relevance of SCM to Pharmaceuticals 155\u003c\/p\u003e \u003cp\u003e7.2 Production Systems and the SCM Holistic 155\u003c\/p\u003e \u003cp\u003e7.3 The Core of SCM 156\u003c\/p\u003e \u003cp\u003e7.4 First Principle of SCM 156\u003c\/p\u003e \u003cp\u003e7.5 Supply Chains as a Series of Interconnected Systems 158\u003c\/p\u003e \u003cp\u003e7.6 Processes to Manage the Supply Chain 160\u003c\/p\u003e \u003cp\u003e7.7 A Word About Processes 161\u003c\/p\u003e \u003cp\u003e7.8 How the SCM Processes Should Mesh Together 163\u003c\/p\u003e \u003cp\u003e7.9 Production and Inventory Control 163\u003c\/p\u003e \u003cp\u003e7.10 Strategic Procurement 163\u003c\/p\u003e \u003cp\u003e7.11 Transportation, Storage, and Distribution 164\u003c\/p\u003e \u003cp\u003e7.12 Information Systems and Technology 164\u003c\/p\u003e \u003cp\u003e7.13 Improvement 165\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Production and Inventory Control 167\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e8.1 Core Mission 167\u003c\/p\u003e \u003cp\u003e8.2 First Principles of Production and Inventory Control 167\u003c\/p\u003e \u003cp\u003e8.3 The Wholesome Trinity in P\u0026amp;IC 174\u003c\/p\u003e \u003cp\u003e8.4 The Wholesome Trinity and Customer Expectations 177\u003c\/p\u003e \u003cp\u003e8.5 Leveraging the Wholesome Trinity 179\u003c\/p\u003e \u003cp\u003e8.6 The Impact of Variety on Supply Chains 180\u003c\/p\u003e \u003cp\u003e8.7 Designing Appropriate Production Systems 183\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Strategic Procurement 187\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e9.1 Core Mission 187\u003c\/p\u003e \u003cp\u003e9.2 The Purchasing Portfolio 188\u003c\/p\u003e \u003cp\u003e9.3 The Process of Procurement 195\u003c\/p\u003e \u003cp\u003e9.4 Strategic Sourcing and Planning 198\u003c\/p\u003e \u003cp\u003e9.5 Outsourcing 201\u003c\/p\u003e \u003cp\u003e9.6 Basic Principles in Contracting for Supply 206\u003c\/p\u003e \u003cp\u003e9.7 Finally, Typical Organizational Tension over Procurement 213\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Transportation, Storage, and Distribution 215\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10.1 Defining the Core Mission 215\u003c\/p\u003e \u003cp\u003e10.2 International Trade and Commerce 217\u003c\/p\u003e \u003cp\u003e10.3 The World Trade Organization 217\u003c\/p\u003e \u003cp\u003e10.4 Intermediary Arrangements 220\u003c\/p\u003e \u003cp\u003e10.5 Terms of Trade: Incoterms 223\u003c\/p\u003e \u003cp\u003e10.6 Ownership of Goods: Title 225\u003c\/p\u003e \u003cp\u003e10.7 Third-Party Logistics Providers 226\u003c\/p\u003e \u003cp\u003e10.8 Customs 227\u003c\/p\u003e \u003cp\u003e10.9 Shipping Regulations Relating to Materials 229\u003c\/p\u003e \u003cp\u003e10.10 A Finishing Note 230\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Information Systems and Information Technology 233\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e11.1 Overview 233\u003c\/p\u003e \u003cp\u003e11.2 Brief Lay History of Computer Systems Development 234\u003c\/p\u003e \u003cp\u003e11.3 Important Perspectives on Information Systems 236\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Improvement 255\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e12.1 Why Improve? 255\u003c\/p\u003e \u003cp\u003e12.2 Improvement and Production Systems 257\u003c\/p\u003e \u003cp\u003e12.3 The Improvement Journey 258\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Bringing the Holistic Together 277\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e13.1 Setting the Scene 277\u003c\/p\u003e \u003cp\u003e13.2 The Process Explained 278\u003c\/p\u003e \u003cp\u003e13.3 Developing an Action Agenda 285\u003c\/p\u003e \u003cp\u003e13.4 Case Study 289\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIII PLANNING AND EXECUTING SUPPLY CHAIN CHANGE 293\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Improvement in Pharmaceuticals 295\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e14.1 Where Are We Now? 295\u003c\/p\u003e \u003cp\u003e14.2 Subsequent Developments Since Inception 310\u003c\/p\u003e \u003cp\u003e14.3 A Blueprint for Quality by Design 311\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Exemplar Thinking in Organizational Improvement 335\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e15.1 Where Are We Now? 335\u003c\/p\u003e \u003cp\u003e15.2 What Is Meant by \"Exemplar\"? 338\u003c\/p\u003e \u003cp\u003e15.3 A Dialogue on Exemplar Improvement 338\u003c\/p\u003e \u003cp\u003e15.4 An Approach to SCM Based on Systems Thinking 357\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Building a Foundation for Sustainable Change 363\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e16.1 Focus on the Individual 363\u003c\/p\u003e \u003cp\u003e16.2 Individuals as Leaders 368\u003c\/p\u003e \u003cp\u003e16.3 Individuals as Motivators and the Motivated 370\u003c\/p\u003e \u003cp\u003e16.4 Individuals as Group Members 372\u003c\/p\u003e \u003cp\u003e16.5 Individuals as Participants in Cultural Change 376\u003c\/p\u003e \u003cp\u003e16.6 Case Study: Miles Ltd., Bridgend, Glamorgan 378\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 A Cure for the Pharmaceutical Supply Chain 395\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e17.1 What Is the Disease State? 395\u003c\/p\u003e \u003cp\u003e17.2 What Is the Label Claim for the Medicine? 396\u003c\/p\u003e \u003cp\u003e17.3 What Will Life Hold Without the Medicine? 397\u003c\/p\u003e \u003cp\u003e17.4 What Is This Better Way to Develop Drugs? 397\u003c\/p\u003e \u003cp\u003e17.5 Full-Scale Production of Drugs 407\u003c\/p\u003e \u003cp\u003e17.6 What Are the Barriers to Change? 410\u003c\/p\u003e \u003cp\u003e17.7 What Are the Potential Benefits of Change? 413\u003c\/p\u003e \u003cp\u003e17.8 Defining the Art of the Possible 414\u003c\/p\u003e \u003cp\u003e17.9 Ending with the Beginning 417\u003c\/p\u003e \u003cp\u003eEND NOTES 419\u003c\/p\u003e \u003cp\u003eINDEX 429\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":53515417878871,"sku":"9780470555170","price":87.26,"currency_code":"GBP","in_stock":true}],"url":"https:\/\/bookcurl.com\/products\/pharma-supply-chain-delivering-patient-value-for-pharmaceuticals-and-biologics-9780470555170","provider":"Book Curl","version":"1.0","type":"link"}